517.13

2.09% -10.78

United Therapeutics Corp (UTHR)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché UTHR Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$527.91

Aprire:

$527.94

Volume 24 ore:

101.95K

Relative Volume:

0.21

Capitalizzazione di mercato:

$22.18B

Reddito:

$3.17B

Utile/perdita netta:

$1.29B

Rapporto P/E:

19.09

EPS:

27.0947

Flusso di cassa netto:

$1.01B

1 W Prestazione:

+0.73%

1M Prestazione:

-1.29%

6M Prestazione:

+2.57%

1 anno Prestazione:

+68.23%

Intervallo 1D:

$515.79

$530.50

Intervallo di 1 settimana:

$508.15

$531.76

Portata 52W:

$303.08

$609.35

United Therapeutics Corp Stock (UTHR) Company Profile

Nome

United Therapeutics Corp

Settore

Healthcare (1088)

Industria

Drug Manufacturers - Specialty & Generic (87)

Telefono

(301) 608-9292

Indirizzo

1000 SPRING ST, SILVER SPRING, MD

Dipendente

1,400

Cinguettio

Prossima data di guadagno

2026-08-05

Ultimi documenti SEC

UTHR's Discussions on Twitter

Compare UTHR vs TAK, HLN, TEVA, ZTS

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
UTHR United Therapeutics Corp	517.14	22.35B	3.17B	1.29B	1.01B	27.09
TAK Takeda Pharmaceutical Co Adr	18.00	57.90B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	10.09	43.41B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	36.50	42.89B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	76.71	31.00B	9.51B	2.64B	2.14B	6.0361

United Therapeutics Corp Stock (UTHR) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-04-10	Iniziato	Raymond James	Outperform
2025-10-20	Iniziato	Wells Fargo	Underweight
2025-09-26	Iniziato	RBC Capital Mkts	Outperform
2025-06-02	Iniziato	Cantor Fitzgerald	Overweight
2025-04-25	Downgrade	Wells Fargo	Overweight → Equal Weight
2025-04-21	Aggiornamento	BofA Securities	Underperform → Neutral
2024-07-11	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2024-02-12	Aggiornamento	Goldman	Sell → Neutral
2024-02-05	Iniziato	Leerink Partners	Outperform
2023-12-08	Iniziato	Wells Fargo	Overweight
2022-12-06	Iniziato	UBS	Buy
2022-12-05	Iniziato	Goldman	Sell
2022-10-11	Iniziato	Morgan Stanley	Overweight
2022-09-20	Reiterato	BofA Securities	Underperform
2022-09-19	Ripresa	Wedbush	Outperform
2022-02-11	Iniziato	BTIG Research	Neutral
2021-07-14	Aggiornamento	Argus	Hold → Buy
2021-04-26	Ripresa	Credit Suisse	Outperform
2021-02-01	Aggiornamento	H.C. Wainwright	Neutral → Buy
2020-09-14	Ripresa	JP Morgan	Overweight
2020-06-25	Reiterato	H.C. Wainwright	Neutral
2020-03-10	Aggiornamento	Jefferies	Hold → Buy
2020-02-27	Aggiornamento	Cowen	Market Perform → Outperform
2020-01-31	Aggiornamento	JP Morgan	Neutral → Overweight
2019-12-03	Iniziato	BofA/Merrill	Underperform
2019-08-01	Aggiornamento	Jefferies	Underperform → Hold
2019-08-01	Aggiornamento	Ladenburg Thalmann	Neutral → Buy
2019-07-01	Aggiornamento	Credit Suisse	Neutral → Outperform
2019-05-17	Aggiornamento	UBS	Sell → Neutral
2019-05-09	Aggiornamento	Credit Suisse	Underperform → Neutral
2018-10-12	Aggiornamento	Standpoint Research	Hold → Buy
2018-08-08	Downgrade	Credit Suisse	Neutral → Underperform
2018-04-03	Aggiornamento	Credit Suisse	Underperform → Neutral
2018-02-22	Reiterato	Barclays	Underweight
2018-01-18	Ripresa	Credit Suisse	Underperform
2017-12-27	Reiterato	Wedbush	Outperform
2017-04-27	Reiterato	Wedbush	Outperform
2017-03-30	Iniziato	UBS	Sell
2017-03-16	Iniziato	Credit Suisse	Underperform

Mostra tutto

United Therapeutics Corp Borsa (UTHR) Ultime notizie

Aug 21, 2026

United Therapeutics (NASDAQ: UTHR) CEO sale part of 1,734,410-option 10b5-1 plan - Stock Titan

Aug 21, 2026

United Therapeutics (UTHR) legal chief sells 8,300 shares - Stock Titan

Aug 21, 2026

Aug 20, 2026

United Therapeutics (NASDAQ: UTHR) CEO trades under 1,734,410-option 10b5-1 plan - Stock Titan

Aug 20, 2026

United Therapeutics (NASDAQ:UTHR) Stands Out as a Quality Stock with Durable Profitability and Strong Returns - ChartMill

Aug 20, 2026

Aug 19, 2026

ETFs Investing in United Therapeutics Corporation Stocks - TradingView

Aug 19, 2026

United Therapeutics (UTHR) CEO sells shares under preset trading plan - Stock Titan

Aug 19, 2026